Cresco Labs (CSE:CL)

  • Symbol:CSE:CL
  • Ticker 2:OTCMKTS:CRLBF
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Charles Bachtell
  • Founded:2013
Categories:

Cresco Labs (CSE:CL) Stock Price

Disclaimer: Past performance is not an indicator of future performance.

Cresco Labs (CSE:CL) Company Overview

Cresco Labs, Inc. (CNSX: CL) is based in Chicago, Illinois, operational in seven U.S. states, with binding transactions pending in New York, Massachusetts and Florida, as well as an approved expansion into Michigan.

The Company expects its acquisition of Origin House to close during the fourth quarter of 2019, which greatly expands its distribution network in California.

Cresco received regulatory approval for its acquisition of Valley Agriceuticals, LLC., providing the Company with one of 10 vertically integrated licenses granted in the State of New York.

Cresco's house of includes Cresco, Remedi and Mindy's, a line of edibles created by James Beard Award-winning chef Mindy Segal and Sunnyside, Cresco's national dispensary brand, with a focus upon wellness and retail experience for both existing and new cannabis consumers.

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Become a Patron below and support us in covering the latest marijuana news!